Zions Bancorporation, National Association’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78K Buy
361
+15
+4% +$2.87K ﹤0.01% 465
2026
Q1
$63.4K Sell
346
-276
-44% -$50.9K ﹤0.01% 486
2025
Q4
$109K Buy
622
+111
+22% +$18.1K 0.01% 505
2025
Q3
$71.6K Buy
511
+139
+37% +$18.8K ﹤0.01% 508
2025
Q2
$46.7K Buy
372
+161
+76% +$20.1K ﹤0.01% 534
2025
Q1
$28.9K Buy
+211
New +$30.2K ﹤0.01% 593

Other funds holding BIIB

Zions Bancorporation, National Association's BIIB Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Biogen (BIIB) stake by 4.3% in Q2 2026, buying an estimated $2.87K and bringing the position to 361 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #465.

Zions Bancorporation, National Association first reported a position in BIIB in Q1 2025 and has held it in 6 quarters since. The position peaked at $109K in Q4 2025. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Zions Bancorporation, National Association held 361 shares of Biogen worth $78K as of Q2 2026.
  • Zions Bancorporation, National Association bought 15 Biogen shares in Q2 2026, an estimated $2.87K.
  • Biogen made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #465 holding.
  • Zions Bancorporation, National Association first reported a position in Biogen in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's Biogen position peaked at $109K in Q4 2025.
  • 405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.